| Ytd | -31.70% | |
| 1y | -32.77% |
| Open | 60.43 | Prev Close | 61.44 | Low | 60.23 | High | 63.01 | Mkt Cap | 1.82B |
| Vol | 514.69K | Avg Vol | 887.38K | EPS | 4.64 | P/E | 13.58 | Forward P/E | 40.99 |
| Beta | 0.67 | Short Ratio | 5.51 | Inst. Own | 130.39% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-02 | 50-d Avg | 53.00 | 200-d Avg | 66.82 | 1yr Est | 60.40 |
MINNEAPOLIS, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire),
ADAR1 Capital Management LLC acquired a new stake in Inspire Medical Systems, Inc. (NYSE: INSP) in t
JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and
Mizuho analyst Anthony Petrone maintains Inspire Medical Systems (NYSE:INSP) with a Outperform an
Oppenheimer analyst Suraj Kalia upgrades Inspire Medical Systems (NYSE:INSP) from Perform to Outp
Truist Securities analyst Richard Newitter reiterates Inspire Medical Systems (NYSE:INSP) with a
US stocks rose, with Dow Jones gaining 500 points on Tue.Caterpillar Inc (CAT) shares surged 8.3% on
Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a
INSPI beats expectations, raises FY26 guidance. Analysts raise price targets to $59 & $60. Stock
Piper Sandler analyst Adam Maeder maintains Inspire Medical Systems (NYSE:INSP) with a Neutral an
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday'
Baird analyst Mike Polark maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock rose 118.1% to $0.61 during Monday's after-mark
Inspire Medical Systems (NYSE:INSP) lowers FY2026 GAAP EPS guidance from $0.07-$0.62 to $(0.42)-$0.1
Inspire Medical Systems (NYSE:INSP) raises FY2026 Adj EPS guidance from $0.75-$1.25 to $1.05-$1.45 v
Inspire Medical Systems (NYSE:INSP) reported quarterly earnings of $0.14 per share which beat the an